There are 2949 resources available
410P - Extent of lymph node (LN) resection and tumour sidedness in operable colon cancer (CC) stage and survival
Presenter: Pedro Simões
Session: E-Poster Display
Resources:
Abstract
411P - A randomized, open-label, parallel-design phase III study to compare adjuvant 5-FU plus oxaliplatin (mFLOX) versus observation in locally advanced rectal cancer after neoadjuvant chemoradiation
Presenter: Maria Ignez Braghiroli
Session: E-Poster Display
Resources:
Abstract
412P - Six-year updated results of Japan Clinical Oncology Group study (JCOG0910): Randomized phase III study of adjuvant chemotherapy with S-1 versus capecitabine in patients with stage III colorectal cancer
Presenter: Tetsuya Hamaguchi
Session: E-Poster Display
Resources:
Abstract
413P - Risk factors for recurrence in patients with high-risk stage II colon cancer after curative resection
Presenter: Hiroki Ohge
Session: E-Poster Display
Resources:
Abstract
414P - Identification of a stemness-related gene signature for predicting prognosis of patients with adjuvant chemotherapy in colorectal cancer
Presenter: Du Cai
Session: E-Poster Display
Resources:
Abstract
415P - Prognostic effect of postoperative serum carcinoembryonic antigen (CEA) combined with T4 versus T3 tumors in patients with high-risk stage 2 colon cancer: ACHIEVE-2 phase III randomized clinical trial
Presenter: Akio Shiomi
Session: E-Poster Display
Resources:
Abstract
416P - A novel prognostic tool based on lymphocyte ratios in patients with stage III colon cancer
Presenter: Debora Basile
Session: E-Poster Display
Resources:
Abstract
417P - Lymph node (LN) retrieval as a high-risk factor in stage II and III colon cancer
Presenter: Yitak Kim
Session: E-Poster Display
Resources:
Abstract
418P - Analysis of the efficacy of cytokine-induced killer cell therapy in adjuvant treatment of colorectal cancer
Presenter: Rui Guo
Session: E-Poster Display
Resources:
Abstract
419P - Minimal residual disease (MRD) detection in colorectal cancer (CRC) using a plasma-only integrated genomic and epigenomic circulating tumor DNA (ctDNA) assay
Presenter: Aparna Parikh
Session: E-Poster Display
Resources:
Abstract